Navigation Links
Delcath Systems Reports Substantial Progress
Date:11/19/2009

NEW YORK, Nov. 19 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. (Nasdaq: DCTH), a medical technology company developing the Delcath Percutaneous Hepatic Perfusion (PHP(TM)) System, a minimally invasive drug delivery platform for the regional treatment of cancer metastatic to the liver, today reported on the Company's recent progress.

"Since we last communicated with our shareholders in late July, our team has achieved many significant milestones as we move into the first regulatory reviews for our PHP System and strive towards European commercialization in 2010," said Eamonn P. Hobbs, President & CEO. "Our most recent accomplishment is yesterday's closing of our common stock public offering, which raised more than $32.4 million and significantly improves our balance sheet. The successful offering met all of the key goals established by the Board of Directors and provides our company with the resources required to execute our regulatory approval and go-to-market strategies. We attracted several leading and internationally known institutional investors to the offering and we fully expect the transaction will shortly lead to new sell-side analyst coverage of the company," added Mr. Hobbs.

Other recent highlights include:

  • Active negotiations continue with several international entities to provide exclusive geographic market rights for the PHP System.
  • In early September, the Data and Safety Monitoring Board ("DSMB") reviewed clinical data on 77 patients enrolled in Delcath's pivotal Phase III clinical trial and unanimously recommended that the trial continue to enroll patients with the goal of reaching the 92 patients required to complete the study.
  • In October, the pivotal Phase III Metastatic Melanoma Trial met its goal of 92 patients and was fully enrolled. This clinical study is evaluati
    '/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
2. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
3. Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Lukes Cancer Center
4. Delcath Adds Dr. Pamela R. Contag to Its Board of Directors
5. Delcath Continues Expansion of Clinical Trial Centers Offering PHP(TM)
6. Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy-Five Percent Accrual
7. Data Safety Monitoring Board Unanimously Recommends Continuation of Delcaths Phase III Clinical Trial
8. Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
9. Delcath Systems, Inc. Completes Phase III Study Enrollment
10. Delcath Systems, Inc. Prices $30.6 Million Stock Offering
11. Delcath Systems Announces Completion of Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 28, 2014  VigeneTech, Inc, in collaboration with ... Data Analysis Software, an OEM software solution for ... develops and offers varieties of bead-based multi-analyte immunoassay ... support of VigeneTech,s data analysis software, FCS data ... easily reported LEGENDplex™ software is ...
(Date:7/28/2014)... , July 28, 2014 Research and Markets ... Drugs Market 2014-2018" report to their offering. ... chronic disease that leads to inflammation and pain in the ... ankles. In addition, it causes inflammation of the tissues that ... The symptoms of RA begin slowly, usually just mild ...
(Date:7/28/2014)... 28, 2014  Syneron Medical Ltd. (NASDAQ: ... today that its new PicoWay® device has received CE ... colors and pigmented lesions on any skin type. PicoWay ... 532nm and 1064nm wavelengths, which utilizes Syneron,s proprietary PicoWay ... which are trillionths of a second, known as picosecond ...
Breaking Medicine Technology:VigeneTech Releases New Powerful Software for Flow Cytometry Data Analysis 2Global Rheumatoid Arthritis Drugs Market 2014-2018 2Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 2Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 3Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 4
... WASHINGTON, Oct. 28, 2011 The National Pharmaceutical Council (NPC) ... North America, has been elected Chairman of its Board of ... since 2008, most recently as Treasurer. "Rich ... landscape is continuing to change at a rapid pace. As ...
... Medical Systems, Inc., a developer of high-end ultrasound solutions, ... President of Business Development & Corporate Accounts.  A 25-year ... ZONARE since 2005. In addition to managing ... U.S. based clinical applications group. Previously Ryland served as ...
Cached Medicine Technology:AstraZeneca's Rich Fante Elected as National Pharmaceutical Council's Chairman of the Board 2ZONARE Medical Systems Announces Appointment of PJ Ryland as Vice President of Business Development & Corporate Accounts 2
(Date:7/28/2014)... 28, 2014 Quincy Bioscience, makers of ... pleased to announce the release of the fourth edition ... and co-founder Mark Underwood. , The Brain Health Guide ... useful techniques for readers to improve memory and promote ... conclusion, The Brain Health Guide provides ways to help ...
(Date:7/28/2014)... 2014 (HealthDay News) -- Elementary school students seem to be ... according to a new study of school officials. , , ... Agriculture -- went into effect in the fall of 2012. ... buying lunch, or throw away most of their food. But ... this isn,t the case. , , "The updated meals standards ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Shofner ... Operation Military June . Renowned LASIK and Cataract ... to provide significant funds and public awareness for ... retired military personnel and their families. “This was ... proudly give nearly $5,000 to a variety of ...
(Date:7/28/2014)... By Maureen Salamon ... (HealthDay News) -- Infants and children who are at ... should be vaccinated against the infection, according to updated ... States. And routine vaccinations for the potentially ... the American Academy of Pediatrics says. In its ...
(Date:7/28/2014)... HealthDay Reporter MONDAY, July 28, 2014 ... irregularities are more likely to get a pacemaker than people ... study of more than 16,000 people found that those with ... a pacemaker than those without the memory-robbing condition. ... dementia are so much more likely to be treated with ...
Breaking Medicine News(10 mins):Health News:Quincy Bioscience Launches the Fourth Edition of The Brain Health Guide 2Health News:Healthy School Lunches Get Thumbs Up From Students 2Health News:Shofner Vision Center’s “Operation Military June” Provided Funds For Local Not-For-Profit Organizations Supporting Military And Their Families 2Health News:Shofner Vision Center’s “Operation Military June” Provided Funds For Local Not-For-Profit Organizations Supporting Military And Their Families 3Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 2Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 3Health News:Pacemakers Common for Those With Dementia and Irregular Heartbeats 2Health News:Pacemakers Common for Those With Dementia and Irregular Heartbeats 3
... unveiled new body-mass index numbers that can be used to ... received an eye-opening letter from her daughter's school which revealed ... heavier than 98 percent of her peers. ,Last ... the backyard, substituting soda for bottled water and eating more ...
... five of them seriously, after eating stale food on Independence ... 44 children of Pratapura Primary School, 60 km from Chhattarpur ... ,The children complained of stomach ache and started vomiting ... earlier. ,They were taken to a primary ...
... Health officials in Rajasthan would now be denied salary increments if ... ,If an official is found neglecting his duties and is unable ... to a period of three years, said a notification issued by ... apply to senior, junior and chief officers of the medical and ...
... thousands of red, yellow, pink and blue condoms have flooded ... sticky issue at the world's largest// AIDS conference. ... sex. It will become like the anti-smoking drives which everyone ... ,"We must be able to talk about sexual ...
... revealed that most of the people suffering from osteoporosis are ... ,According to the research by the University of ... affected by osteoporosis, the problem is not being managed efficiently. ... Health in Western Australia, carried out a study on 366 ...
... only remedy for many ills, and AIDS/HIV is also one ... who are educated till the secondary levels show a// tendency ... at the first opportunity. The educated lot was well aware ... report on HIV. ,The statistics in Africa ...
Cached Medicine News:Health News:Childhood Obesity Tackled in Arkansas 2Health News:Safe Sex and Good Sex is the Talk of AIDS Conference 2Health News:Negligence in Osteoporosis treatment 2
Aplicare's disposable 1-ounce pouches are designed for individual application and are ideal for reducing waste. They are used in nursing homes, home healthcare settings, blood banks, laboratories, em...
... a gentle and effective surgical scrub with ... Iodine is known to kill skin surface ... viruses, protozoa and yeasts. It produces a ... patient pre-operative prepping, as well as for ...
... is appropriate for pre-surgical patient preparation ... spray); disinfecting of wounds and burns; ... and abrasions. It also acts as ... and office procedures, providing protection against ...
Pre-Saturated Sponge Sticks...
Medicine Products: